[Prevention of neutropenia during adjuvant taxotere therapy for breast cancer]

Vopr Onkol. 2012;58(6):813-6.
[Article in Russian]
No abstract available

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery*
  • Caproates
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Docetaxel
  • Doxorubicin / administration & dosage
  • Drug Administration Schedule
  • Female
  • Hematologic Agents / administration & dosage
  • Hematologic Agents / therapeutic use*
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / therapeutic use*
  • Leukopenia / prevention & control
  • Middle Aged
  • Neoplasm Staging
  • Neutropenia / chemically induced
  • Neutropenia / prevention & control*
  • Taxoids / administration & dosage
  • Taxoids / adverse effects*
  • Treatment Outcome

Substances

  • Caproates
  • Hematologic Agents
  • Imidazoles
  • Taxoids
  • Docetaxel
  • pentanedioic acid imidazolyl ethanamide
  • Doxorubicin
  • Cyclophosphamide